
|Articles|May 23, 2007
Wyeth CFO and VC to Leave the Company
Author(s)BioPharm International Editors
Kenneth J. Martin, Wyeth's (Madison, NJ, www.wyeth.com) chief financial officer and vice chairman, has announced plans to leave the company at the end of June.
Advertisement
Kenneth J. Martin, Wyeth’s (Madison, NJ,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
3
SK bioscience Licensing Deal Targets Access Gaps in RSV Prevention
4
Industry Outlook 2026: How AI and Payer Pressure Impact Biopharma R&D (Part 1)
5




